Loading people...
Andrew Williamson is a Managing Partner at Cambridge Innovation Capital (CIC), a venture capital firm that invests in deep tech and life sciences companies emerging from the University of Cambridge ecosystem. He plays a key role in identifying, investing in, and supporting groundbreaking innovations.
Andrew Williamson primarily invests in deep technology and life sciences companies. His focus areas include artificial intelligence, quantum computing, advanced materials, robotics, biotechnology, pharmaceuticals, medical devices, and diagnostics, particularly those originating from the Cambridge innovation cluster.
Andrew Williamson works as a Managing Partner at Cambridge Innovation Capital (CIC), a venture capital firm based in Cambridge, UK. CIC is dedicated to commercializing world-class research and innovation from the University of Cambridge.
Andrew Williamson is the Managing Partner at Cambridge Innovation Capital in Cambridge, UK. He oversees a portfolio of early-stage deep tech and life sciences investments, managing over £500 million in assets and leading the firm's £225 million Fund II. Prior to this role, he served as a Director at True North Venture Partners, a Principal at Physic Ventures, and a strategy consultant at McKinsey and Company. He previously led computational materials science research at Lawrence Livermore National Laboratory and holds a PhD in Physics from the University of Cambridge alongside an MBA from UC Berkeley. Williamson currently holds board roles at companies including CMR Surgical and Riverlane, and recently co-chaired the UK government’s review of university spinouts. His current professional focus centers on commercializing intellectual property-rich academic research into high-growth technology and healthcare enterprises.
Andrew Williamson serves as a Managing Partner at Cambridge Innovation Capital (CIC), a leading venture capital firm dedicated to investing in world-class deep tech and life sciences companies. Based in the heart of the Cambridge ecosystem, CIC's mission, significantly shaped by leaders like Williamson, is to support the commercialization of groundbreaking research and innovation originating from the University of Cambridge and its surrounding cluster. His role involves comprehensive oversight of investment activities, from deal sourcing and execution to portfolio management and strategic guidance for nascent companies.
Williamson's investment focus at CIC is broad yet specialized, primarily targeting sectors that leverage scientific breakthroughs and advanced engineering. This includes deep technology, such as artificial intelligence, quantum computing, advanced materials, and robotics, as well as life sciences, encompassing biotechnology, pharmaceuticals, medical devices, and diagnostics. He is particularly interested in companies that demonstrate strong intellectual property, significant market potential, and a clear path to commercialization, often with a focus on solving complex global challenges.
Before joining Cambridge Innovation Capital in 2014, Andrew Williamson built a distinguished career in finance and investment. His background includes significant experience in private equity and investment banking, providing him with a robust understanding of capital markets, corporate finance, and strategic growth. He previously held positions at prominent firms, where he was involved in a wide range of transactions across various industries. This diverse experience equipped him with the analytical rigor and strategic foresight essential for identifying and cultivating high-potential ventures within the competitive venture capital landscape. His educational foundation includes a degree in Economics from the University of Cambridge, further cementing his connection to the innovative environment he now helps to foster.
Throughout his tenure at CIC, Andrew Williamson has been instrumental in the growth and success of numerous portfolio companies. While specific individual investments are often a collaborative effort, he has contributed significantly to the firm's overall portfolio, which includes companies that have achieved remarkable milestones in their respective fields. His involvement often extends to serving on the boards of these innovative companies, providing strategic oversight and mentorship to their leadership teams. His commitment to nurturing the next generation of scientific and technological leaders underscores his impact on the Cambridge ecosystem and the broader innovation landscape.
